AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Myovant SciencesEndo InternationalCytokineticsApplied TherapeuticsHomology Medicines
SymbolNYSE:MYOVNASDAQ:ENDPNASDAQ:CYTKNASDAQ:APLTNASDAQ:FIXX
Price Information
Current Price$17.75$3.63$21.11$46.41$15.93
52 Week RangeBuyHoldBuyBuyBuy
Beat the Market™ Rank
Overall Score1.91.51.81.21.7
Analysis Score3.43.14.52.54.5
Community Score2.62.63.52.42.6
Dividend Score0.00.00.00.00.0
Ownership Score3.01.01.01.01.0
Earnings & Valuation Score0.60.60.00.00.6
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyBuy
Consensus Price Target$27.00$5.72$26.43$55.20$33.50
% Upside from Price Target52.11% upside57.54% upside25.19% upside18.94% upside110.30% upside
Trade Information
Market Cap$1.10 billion$886.66 million$1.24 billion$1.00 billion$643.84 million
Beta2.561.551.41N/A-0.05
Average Volume1,030,4766,148,647931,066225,089348,812
Sales & Book Value
Annual RevenueN/A$2.91 billion$26.87 millionN/A$1.67 million
Price / SalesN/A0.2946.72N/A431.28
CashflowN/A$4.91 per shareN/AN/AN/A
Price / CashN/A0.74N/AN/AN/A
Book Value($1.21) per share($3.82) per share($0.19) per shareN/A$5.73 per share
Price / BookN/A-0.95-111.11N/A2.78
Profitability
Net Income$-288,990,000.00$-422,640,000.00$-121,690,000.00N/A$-103,920,000.00
EPS($3.37)$2.38($2.11)($3.55)($2.47)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/A1.59N/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-9.09%-592.61%N/A-5,816.28%
Return on Equity (ROE)-2,288.94%-91.00%-10,351.99%N/A-44.92%
Return on Assets (ROA)-172.45%6.73%-56.54%N/A-36.71%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio5.88%N/AN/AN/AN/A
Current Ratio1.02%2.03%10.89%N/A13.66%
Quick Ratio1.02%1.79%10.89%N/A13.66%
Ownership Information
Institutional Ownership Percentage34.22%82.32%93.71%43.90%81.86%
Insider Ownership Percentage3.68%2.30%6.40%N/A28.00%
Miscellaneous
Employees863,1721304124
Shares Outstanding89.87 million229.71 million59.47 million21.97 million45.21 million
Next Earnings Date8/4/2020 (Estimated)8/3/2020 (Estimated)8/13/2020 (Estimated)8/10/2020 (Estimated)8/13/2020 (Estimated)
OptionableNot OptionableOptionableOptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.